Farid Ramy
- SEC CIK
- 0001797707
In the past year, 3 open-market sale filings worth $1.17M and no purchases.
Current role at each company
- VIR Vir Biotechnology, Inc.Directoras of May 28, 2026
- SDGR Schrodinger, Inc.President & CEOas of Apr 17, 2026
- GPCR Structure Therapeutics Inc.Directoras of Feb 9, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.17M
- 3 filings
- Net
- −$1.17M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Farid Ramy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SDGR Schrodinger, Inc.
President & CEO4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2026 (view filing) | Apr 16-17 | 1 day | Farid RamyPresident & CEO | SSale | −86.0K | $12.27 | −$1.06M | −20.6%330.8K after | 2 lots10b5-1 |
| Mar 6, 2026 (view filing) | Mar 5 | 1 day | Farid RamyPresident & CEO | SSale | −3.66K | $12.91 | −$47.3K | −1.1%330.8K after | 10b5-1 |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Farid RamyPresident & CEO | SSale | −5.56K | $11.90 | −$66.2K | −1.6%334.5K after | 10b5-1 |
| Jan 5, 2023 (view filing) | Jan 4 | 1 day | Farid RamyPresident & CEO | SSale | −66.9K | $18.28 | −$1.22M | −26.6%184.4K after |
GPCR Structure Therapeutics Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2023 (view filing) | Feb 7 | 2 days | Farid RamyDirector | PPurchase | +825.0K | $5.00 | +$4.13M | –275.0K after | Derivative |